HAYA Therapeutics

Biotechnology company developing precision RNA-guided medicines targeting tissue-selective long non-coding RNAs (lncRNAs) for chronic and age-related fibrotic diseases.

Location
Lausanne, Switzerland
Founded
2015
Investors
1
Categories
therapeutics, biotech, rna-therapeutics, longevity-research, fibrosis

Investors

NameLocationTypeStagesPortfolio
Apollo Health VenturesDusseldorf, Germany / Boston, USAbiotech-focused
seedseries-a+1
15